{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Three point mutations in αSyn (A30P, E46K, A53T) are associated with early-onset familial Parkinson’s disease (PD) and affect αSyn’s amyloidogenicity and vesicle-binding activity.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 2: Evaluate the assay's applicability",
          "extracted_paper_info": "The study examines proteasome-mediated cleavage of αSyn and its correlation with oligomer formation, which is directly relevant to the disease mechanism (proteasome dysfunction and αSyn aggregation).",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 3a: Basic controls and replicates",
          "extracted_paper_info": "The study compares mutant αSyn (A30P, E46K, A53T) with wildtype αSyn but does not explicitly mention known pathogenic/benign control variants or statistical replicates in the abstract.",
          "judgment": "No"
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "In vitro proteasome cleavage and oligomerization assays are standard techniques in the field of αSyn aggregation research.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study does not report statistical significance (e.g., p-values) or OddsPath values for the correlation between mutations and oligomer formation rates.",
          "judgment": "Yes"
        }
      ],
      "strength": "PS3_supporting",
      "overall_conclusion": "The A30P mutation correlates with increased oligomer formation rates, which is a pathogenic mechanism in PD."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "E",
          "alt": "K",
          "position": "46"
        },
        "variant_string_id": "SNCA E46K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "E46K is one of three mutations in αSyn associated with early-onset familial PD, affecting amyloidogenicity and vesicle-binding activity.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 2: Evaluate the assay's applicability",
          "extracted_paper_info": "The study examines proteasome-mediated cleavage of αSyn and its correlation with oligomer formation, which is directly relevant to the disease mechanism.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 3a: Basic controls and replicates",
          "extracted_paper_info": "The study compares mutant αSyn (E46K) with wildtype αSyn but does not explicitly mention known pathogenic/benign control variants or statistical replicates in the abstract.",
          "judgment": "No"
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "In vitro proteasome cleavage and oligomerization assays are standard techniques in the field of αSyn aggregation research.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study does not report statistical significance (e.g., p-values) or OddsPath values for the correlation between mutations and oligomer formation rates.",
          "judgment": "Yes"
        }
      ],
      "strength": "PS3_supporting",
      "overall_conclusion": "The E46K mutation correlates with increased oligomer formation rates, which is a pathogenic mechanism in PD."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "A53T is one of three mutations in αSyn associated with early-onset familial PD, affecting amyloidogenicity and vesicle-binding activity.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 2: Evaluate the assay's applicability",
          "extracted_paper_info": "The study examines proteasome-mediated cleavage of αSyn and its correlation with oligomer formation, which is directly relevant to the disease mechanism.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 3a: Basic controls and replicates",
          "extracted_paper_info": "The study compares mutant αSyn (A53T) with wildtype αSyn but does not explicitly mention known pathogenic/benign control variants or statistical replicates in the abstract.",
          "judgment": "No"
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "In vitro proteasome cleavage and oligomerization assays are standard techniques in the field of αSyn aggregation research.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study does not report statistical significance (e.g., p-values) or OddsPath values for the correlation between mutations and oligomer formation rates.",
          "judgment": "Yes"
        }
      ],
      "strength": "PS3_supporting",
      "overall_conclusion": "The A53T mutation correlates with increased oligomer formation rates, which is a pathogenic mechanism in PD."
    }
  ]
}